Takeda Pharmaceutical to invest $30bn in US over 5 years: CEO
TAITO KUROSE and HINAKO BANNO
TOKYO -- Japanese drugmaker Takeda Pharmaceuticals will invest $30 billion in the U.S. over the next five years, CEO Christophe Weber said Thursday, with the money going toward both manufacturing facilities and research and development.
A string of major pharmaceutical makers around the world have come out with plans to invest in the U.S. after the Trump administration said that it was considering tariffs on drugs and medical products.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
2 hours ago
Japan Govt Loses Suit over Abenomasks
News from Japan Society Jun 5, 2025 18:05 (JST) Osaka, June 5 (Jiji Press)--A district court on Thursday partially nullified the Japanese government's decision not to disclose documents regarding the procurement of "Abenomasks," cloth masks distributed in the early days of the COVID-19 pandemic. Atsushi Tokuchi, presiding judge at Osaka District Court, also ordered the state to pay 110,000 yen in damages to the plaintiff, Kobe Gakuin University professor Hiroshi Kamiwaki. Kamiwaki had filed a suit demanding the revocation of the government decision, saying that it was illegal not to disclose the documents containing detailed information about the state's procurement contracts. In April 2020, then Prime Minister Shinzo Abe announced plans to distribute cloth masks to all households in an effort to combat the pandemic. The government signed 32 no-bid contracts with 17 companies to distribute the masks, including those provided to elderly care facilities and elementary and junior high schools. In total, the government procured some 318 million masks for around 44.3 billion yen. [Copyright The Jiji Press, Ltd.] Jiji Press
Japan Today
4 hours ago
- Japan Today
4 arrested in Japan for alleged sale of ivory as mammoth tusks
Japanese police have arrested four people for allegedly selling at an online auction elephant tusks as mammoth tusks to evade a trade ban, police said. Nobumasa Daigo, a 58-year-old executive of Daigo Ivory Co that processes and sells ivory products, and three other family members who work for the company based in Saitama Prefecture, were arrested Monday on suspicion of violating the Unfair Competition Prevention Act that prohibits misleading labeling of goods. Tokyo's Metropolitan Police Department, which led the investigation, suspects the company annually sold elephant tusks and ivory products worth around 100 million yen by labeling them as coming from mammoths, an extinct species. The four were arrested on suspicion of selling such products totaling some 126,500 yen to four male customers via an auction site between October 2022 and November 2023, police said, adding the case came to light after a tip from the Ministry of Economy, Trade and Industry. The suspects have admitted to the allegations, according to the police. The Convention on International Trade in Endangered Species of Wild Fauna and Flora, also known as the Washington Convention, bans in principle international trade in ivory to thwart the threat of poaching of elephants. Elephant tusks have been traded under the guise of mammoth tusks as they are hard to distinguish, according to environmental organization the Japan Tiger and Elephant Fund. In Japan, commercial trade in elephant tusks is allowed if they are certified by a state-backed organization as legally obtained tusks. © KYODO
Yomiuri Shimbun
4 hours ago
- Yomiuri Shimbun
Japan's Nikkei Stock Average Shares End Lower on Caution over US Economic Outlook
Yomiuri Shimbun file photo The Tokyo Stock Exchange TOKYO, June 5 (Reuters) – Japanese shares ended lower on Thursday, with automakers leading the declines, as weak U.S. economic data fueled caution toward the outlook of the world's largest economy. The Nikkei closed 0.51% lower at 37,554.49, while the broader Topix lost 1.03% to 2,756.47. Overnight, U.S. data showed the smallest gain in private payrolls since March 2023 while the service sector contracted for the first time in about a year. 'The market had not expected to see the weak data out of the U.S., so now investors have become cautious about Friday's employment report,' said Shuutarou Yasuda, a market analyst at Tokai Tokyo Intelligence Laboratory. 'But the weak economic data means the Federal Reserve may lower interest rates, which is positive for equities. So investors do not have to switch to risk-off mode,' Yasuda said. Shares of Suzuki Motor dropped 3% after a Reuters report revealed the automaker had suspended production of its Swift model, citing disruptions tied to China's rare-earth export restrictions. Toyota Motor and Honda Motor fell 2.72% and 2.67%, respectively, pressured by the yen's overnight gain against the dollar. Overall, automakers and auto parts makers fell 4.66%. The dollar weakened across the board overnight, sending the yen as high as 142.6. The yen was last down 0.3% at 143.185. A stronger Japanese currency tends to hurt shares of exporters, as it decreases the value of overseas profit in yen terms when repatriated to Japan. Bank shares fell as U.S. Treasury yields declined overnight, with Mitsubishi UFJ Financial Group and Sumitomo Mitsui Financial Group slipping 1.39% and 0.93%, respectively. Chip-related heavyweights rose to track overnight gains in the technology-heavy Nasdaq Composite. Advantest jumped 4.57% and Tokyo Electron rose 3.78%, providing the biggest support to the Nikkei. Of more than 1,600 stocks trading on the Tokyo Stock Exchange's prime market, 34% rose, 61% declined and 4% were flat.
